Increasing access to immuno-oncology therapies in Brazil

Immuno-therapeutics have revolutionized the field of oncology. The Brazilian cancer population would unquestionably benefit from an increase in the availability of cost-effective immuno-oncologic drugs. The challenge is how to incorporate these into the toolbox of health professionals, given the complexity and inequities of the Brazilian healthcare system, limiting financial resources and numerous health needs. We provide a series of recommendations that are likely to improve access and reduce the cost of these important medications. Nonetheless, there are numerous challenges that must be overcome if the entire Brazilian cancer population is to benefit from this remarkable advancement in health care.